Cite
HARVARD Citation
Lovell, D. et al. (n.d.). A169: Cumulative Long‐Term Safety, Efficacy and Patient‐Reported Outcomes in Children With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept: Up to 7 Years of Treatment. Arthritis & rheumatology. 66 (11), pp. S218-S219. [Online].